Teladoc Health Inc. (NYSE:TDOC) went up by 2.29% from its latest closing price compared to the recent 1-year high of $308.00. The company’s stock price has collected 0.40% of gains in the last five trading sessions. Barron’s reported on 07/19/21 that Nasdaq Is Down for a 5th Straight Day. Investors Return to Stay-at-Home Plays.
Is It Worth Investing in Teladoc Health Inc. (NYSE :TDOC) Right Now?
Plus, the 36-month beta value for TDOC is at 0.26. Opinions of the stock are interesting as 17 analysts out of 30 who provided ratings for Teladoc Health Inc. declared the stock was a “buy,” while 1 rated the stock as “overweight,” 11 rated it as “hold,” and 1 as “sell.”
The average price from analysts is $226.85, which is $75.0 above the current price. TDOC currently public float of 145.57M and currently shorts hold a 11.83% ratio of that float. Today, the average trading volume of TDOC was 2.98M shares.
TDOC’s Market Performance
TDOC stocks went up by 0.40% for the week, with a monthly drop of -0.95% and a quarterly performance of -14.42%, while its annual performance rate touched -31.87%. The volatility ratio for the week stands at 4.30% while the volatility levels for the past 30 days are set at 3.68% for Teladoc Health Inc.. The simple moving average for the period of the last 20 days is -2.64% for TDOC stocks with a simple moving average of -21.09% for the last 200 days.
Analysts’ Opinion of TDOC
Many brokerage firms have already submitted their reports for TDOC stocks, with Robert W. Baird repeating the rating for TDOC by listing it as a “Neutral.” The predicted price for TDOC in the upcoming period, according to Robert W. Baird is $162 based on the research report published on May 28th of the current year 2021.
Needham, on the other hand, stated in their research note that they expect to see TDOC reach a price target of $235. The rating they have provided for TDOC stocks is “Buy” according to the report published on April 15th, 2021.
BTIG Research gave a rating of “Buy” to TDOC, setting the target price at $240 in the report published on January 07th of the current year.
TDOC Trading at 1.89% from the 50-Day Moving Average
After a stumble in the market that brought TDOC to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -49.73% of loss for the given period.
Volatility was left at 3.68%, however, over the last 30 days, the volatility rate increased by 4.30%, as shares sank -0.36% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +2.51% upper at present.
During the last 5 trading sessions, TDOC rose by +0.40%, which changed the moving average for the period of 200-days by -29.84% in comparison to the 20-day moving average, which settled at $159.00. In addition, Teladoc Health Inc. saw -22.57% in overturn over a single year, with a tendency to cut further losses.
Reports are indicating that there were more than several insider trading activities at TDOC starting from Trencher Daniel, who sale 2,000 shares at the price of $160.30 back on Jul 12. After this action, Trencher Daniel now owns 23,486 shares of Teladoc Health Inc., valued at $320,600 using the latest closing price.
GOREVIC JASON N, the Chief Executive Officer of Teladoc Health Inc., sale 10,000 shares at $162.92 during a trade that took place back on Jul 06, which means that GOREVIC JASON N is holding 455,970 shares at $1,629,158 based on the most recent closing price.
Stock Fundamentals for TDOC
Current profitability levels for the company are sitting at:
- -37.42 for the present operating margin
- +57.92 for the gross margin
The net margin for Teladoc Health Inc. stands at -44.35. The total capital return value is set at -4.34, while invested capital returns managed to touch -5.16. Equity return is now at value -7.40, with -6.40 for asset returns.
Based on Teladoc Health Inc. (TDOC), the company’s capital structure generated 9.30 points at debt to equity in total, while total debt to capital is 8.51. Total debt to assets is 8.07, with long-term debt to equity ratio resting at 8.96. Finally, the long-term debt to capital ratio is 8.20.
When we switch over and look at the enterprise to sales, we see a ratio of 17.17, with the company’s debt to enterprise value settled at 0.08. The receivables turnover for the company is 9.67 and the total asset turnover is 0.11. The liquidity ratio also appears to be rather interesting for investors as it stands at 3.19.